You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary immunization

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunogenicity of After Primary Immunization and Booster

Active, not recruiting
  • Polio
  • no intervention
  • Pingxiang, Jiangxi, China
    Shangli Center for Disease Control and Prevention
Sep 21, 2023

COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),

Recruiting
  • COVID-19
  • COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
  • COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
  • Huai'an, Jiangsu, China
    Huaiyin Center for Disease Control and Prevention
Jan 11, 2023

Poliomyelitis Trial in Gao'an, Pingxiang (sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inactivated vaccine /MMR

Recruiting
  • Poliomyelitis
  • sIPV vaccine /DTaP vaccine
  • sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine
  • Gao'an, Jiangxi, China
  • +1 more
Jun 20, 2022

Varicella Trial in Kaifeng (Investigational live attenuated varicella vaccine)

Completed
  • Varicella
  • Investigational live attenuated varicella vaccine
  • Kaifeng, Henan, China
    Xiangfu County Center for Disease Control and Prevention
Dec 8, 2021

Japanese Encephalitis Trial in Gyeonggi-do, Seoul, Wonju (IMOJEV)

Completed
Has Results
  • Japanese Encephalitis
  • IMOJEV
  • Gyeonggi-do, Korea, Republic of
  • +7 more
Mar 21, 2022

COVID-19 Trial in Beijing (High-dosage of COVID-19 vaccine (Vero cell), Inactivated, Medium-dose COVID-19 Vaccine(Vero

Completed
  • COVID-19
  • High-dosage of COVID-19 vaccine (Vero cell), Inactivated
  • Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated
  • Beijing, Beijing, China
    Beijing Youan Hospital Capital Medical University
Aug 9, 2022

Coronavirus Infection Trial (INO-4800, INO-9112, CELLECTRA® 2000)

Not yet recruiting
  • Coronavirus Infection
  • (no location specified)
Jun 21, 2022

Varicella Trial in Xuchang, Zhumadian (Investigational Live Attenuated Varicella Vaccine, Placebo (Freeze Dired Dilution))

Not yet recruiting
  • Varicella
  • Investigational Live Attenuated Varicella Vaccine
  • Placebo (Freeze Dired Dilution)
  • Xuchang, Henan, China
  • +1 more
Oct 14, 2021

Polio, Vaccine Reaction Trial in Hangzhou, Quzhou (vaccinated with Sabin IPV, vaccinated with bOPV)

Completed
  • Polio
  • Vaccine Reaction
  • vaccinated with Sabin IPV
  • vaccinated with bOPV
  • Hangzhou, Zhejiang, China
  • +1 more
Mar 3, 2022

Post Authorization Safety Study Moderna COVID-19 Primary Vaccine

Completed
  • COVID-19
  • Moderna COVID-19 Vaccine
  • Jakarta Pusat, Jakarta, Indonesia
  • +17 more
Aug 22, 2023

Virus Diseases Trial in Hradec Kralove (Encepur Adults)

Completed
  • Virus Diseases
  • Encepur Adults
  • Hradec Kralove, Czechia
    GSK Investigational Site
Jul 4, 2022

Tick Borne Encephalitis, Virus Diseases Trial in Hradec Kralove (Blood draw)

Completed
Has Results
  • Tick Borne Encephalitis
  • Virus Diseases
  • Blood draw
  • Hradec Kralove, Czechia
    GSK Investigational Site
Aug 11, 2021

Pain, Anxiety Trial in Singapore (Virtual Reality Headset)

Completed
  • Pain
  • Anxiety
  • Virtual Reality Headset
  • Singapore, Singapore
    SingHealth Polyclinics-Sengkang
Feb 6, 2021

Immunization, Vaccination Trial in Itasca (STOP-HPV prompts intervention)

Active, not recruiting
  • Immunization
  • Vaccination
  • STOP-HPV prompts intervention
  • Itasca, Illinois
    American Academy of Pediatrics
Jan 11, 2022

Immunization; Infection, Educational Problems, Information Seeking Behavior Trial in Jada (Information Provision)

Completed
  • Immunization; Infection
  • +2 more
  • Information Provision
  • Jada, Adamawa, Nigeria
    Jada Local Government Primary Health Care Development Agency
Jul 11, 2020

Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar

Recruiting
  • Streptococcus Pneumoniae Infection
  • 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
  • Prevenar 13
  • Hechi City, Guangxi Zhuang Autonomous Region, China
  • +4 more
Feb 26, 2023

COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)

Active, not recruiting
  • COVID-19
  • Inactivated COVID-19 Vaccine
  • Weihai, Shandong, China
    Rushan City Center for Disease Control and Prevention
Jul 11, 2022

Immunization, Vaccination Trial in Itasca (STOP-HPV bundle intervention)

Recruiting
  • Immunization
  • Vaccination
  • STOP-HPV bundle intervention
  • Itasca, Illinois
    American Academy of Pediatrics
Dec 9, 2020

Vaccination, Immunization Trial in Itasca (The STOP-HPV Trial 6: Maintenance)

Recruiting
  • Vaccination
  • Immunization
  • The STOP-HPV Trial 6: Maintenance
  • Itasca, Illinois
    American Academy of Pediatrics
Dec 9, 2020

COVID-19 Trial in Natal, São Paulo (SCB-2019/Clover, AstraZeneca/Fiocruz, Pfizer/Wyeth)

Active, not recruiting
  • COVID-19
  • SCB-2019/Clover
  • +2 more
  • Natal, Rio Grande Do Norte, Brazil
  • +1 more
Apr 10, 2023

Lyme Borreliosis, Nervous System Trial in La Mesa, Lincoln, Ghent (VLA15 with Alum, VLA15 without Alum)

Completed
  • Lyme Borreliosis, Nervous System
  • VLA15 with Alum
  • VLA15 without Alum
  • La Mesa, California
  • +2 more
Dec 16, 2022

COVID-19 Trial in Tongren (Experimental vaccine 1, Experimental vaccine 2, Experimental vaccine 3)

Suspended
  • COVID-19
  • Experimental vaccine 1
  • +2 more
  • Tongren, Guizhou, China
    Yanhe Tujia Autonomous County Center for Disease Control and Pre
Aug 9, 2022

Tuberculosis, Diphtheria, Tetanus Trial in Various Cities (All Babies Are Equal Initiative (conditional cash transfer program))

Completed
  • Tuberculosis
  • +10 more
  • All Babies Are Equal Initiative (conditional cash transfer program)
  • Various Cities, Jigawa, Nigeria
  • +2 more
Mar 27, 2020

Isotype Switching and Neutralizing Capacity to COVID-19 Variants

Active, not recruiting
  • COVID-19
    • Beijing, China
      Center for Disease Control and Prevention
    Oct 19, 2021

    COVID-19 Trial (Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector), Bivalent Recombinant COVID-19 Vaccine

    Not yet recruiting
    • COVID-19
    • Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector)
    • +2 more
    • (no location specified)
    Jul 5, 2022